Browsing Tag
Aurobindo Pharma USA Inc.
1 post
Aurobindo Pharma clears FTC hurdle for $250m Lannett acquisition
Aurobindo Pharma clears the FTC hurdle for its $250 million Lannett deal. Explore divestitures, US expansion, integration risks and stock outlook.